{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T21:43:52Z","timestamp":1792619032732,"version":"4.5.0"},"reference-count":74,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T00:00:00Z","timestamp":1587513600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Neuroborreliosis (NB) and neurosyphilis (NS) are abnormal conditions caused by spirochetal bacteria which affect the nervous system. Diagnosis of neuroborreliosis and neurosyphilis is determined by clinical examination of visible symptoms, serum and cerebrospinal fluid (CSF) analysis, and serological detection of antibodies against Borrelia burgdorferi sensu lato and Treponema pallidum, respectively. Establishing a diagnosis may sometimes pose a number of diagnostic difficulties. A potential role of chemokine ligand 13 (CXCL13) as an accurate diagnostic biomarker of intrathecal inflammation has been suggested. In this review, we focused on changes in serum and cerebrospinal fluid concentration of chemokine ligand 13 in selected spirochetal neurological diseases neuroborreliosis and neurosyphilis reported in the available literature. We performed an extensive search of the literature relevant to our investigation via the MEDLINE\/PubMed database. It has been proven that CXCL13 determination can provide rapid information regarding central nervous system inflammation in patients with selected spirochetosis. We described that neuroborreliosis and neurosyphilis are associated with an elevated CXCL13 concentration, mainly in the cerebrospinal fluid. Moreover, literature data suggest that CXCL13 determination is the most interesting additional marker for diagnosis and monitoring of neuroborreliosis and neurosyphilis thanks to its high sensitivity. Based on these published findings, we suggest that CXCL13 has high diagnostic utility and may be applied in laboratory diagnostics as a potential diagnostic marker in human spirochetal neurologic diseases.<\/jats:p>","DOI":"10.3390\/ijms21082927","type":"journal-article","created":{"date-parts":[[2020,4,23]],"date-time":"2020-04-23T02:10:52Z","timestamp":1587607852000},"page":"2927","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Chemokine Ligand 13 (CXCL13) in Neuroborreliosis and Neurosyphilis as Selected Spirochetal Neurological Diseases: A Review of Its Diagnostic Significance"],"prefix":"10.3390","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4854-7155","authenticated-orcid":false,"given":"Monika","family":"Gudowska-Sawczuk","sequence":"first","affiliation":[{"name":"Department of Biochemical Diagnostics, Medical University of Bialystok, 15-269 Bialystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4075-8479","authenticated-orcid":false,"given":"Barbara","family":"Mroczko","sequence":"additional","affiliation":[{"name":"Department of Biochemical Diagnostics, Medical University of Bialystok, 15-269 Bialystok, Poland"},{"name":"Department of Neurodegeneration Diagnostics, Medical University of Bialystok, 15-269 Bialystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,4,22]]},"reference":[{"key":"ref_1","unstructured":"Ryan, S.J., Schachat, A.P., and Sadda, S.R. (2013). Spirochetal infections. Retina, Saunders Elsevier. [5th ed.]."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1212\/CON.0000000000000645","article-title":"Neuroborreliosis and Neurosyphilis","volume":"24","author":"Halperin","year":"2018","journal-title":"CONTINUUM Lifelong Learn. Neurol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1172\/JCI12484","article-title":"Borrelia burgdorferi sensu lato and Treponema pallidum, a comparison of functional genomics, environmental adaptations, and pathogenic mechanisms","volume":"107","author":"Porcella","year":"2001","journal-title":"J. Clin. Investig."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1128\/CVI.00341-09","article-title":"Humoral immune responses in patients with Lyme neuroborreliosis","volume":"17","author":"Cerar","year":"2010","journal-title":"Clin. Vaccine Immun."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1212\/WNL.0b013e318211c39a","article-title":"A prospective study on the role of CXCL13 in Lyme neuroborreliosis","volume":"76","author":"Schmidt","year":"2011","journal-title":"Neurolology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12987-015-0008-8","article-title":"The chemokine CXCL13 is elevated in the cerebrospinal fluid of patients with neurosyphilis","volume":"12","author":"Dersch","year":"2015","journal-title":"Fluids Barriers CNS"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Borde, J.P., Meier, S., Fingerle, V., Klier, C., H\u00fcbner, J., and Kern, W.V. (2012). CXCL13 may improve diagnosis in early neuroborreliosis with atypical laboratory findings. BMC Infect. Dis., 12.","DOI":"10.1186\/1471-2334-12-344"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1007\/s10096-018-3334-3","article-title":"The chemokine CXCL13 in cerebrospinal fluid in children with Lyme neuroborreliosis","volume":"37","author":"Henningsson","year":"2018","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1128\/JCM.00084-11","article-title":"Discriminating Lyme neuroborreliosis from other neuroinflammatory disease level CXCL13 in cerebrospinal fluid","volume":"49","author":"Bakels","year":"2011","journal-title":"J. Clin. Microbiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"4351","DOI":"10.1128\/IAI.01642-06","article-title":"Borrelia garinii induces CXCL13 production in human monocytes through Toll-like receptor 2","volume":"75","author":"Rupprecht","year":"2007","journal-title":"Infect. Immun."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1186\/s40064-016-2462-4","article-title":"CXCL13 chemokine as a promising biomarker to diagnose neurosyphilis in HIV-negative patients","volume":"5","author":"Zeng","year":"2016","journal-title":"SpringerPlus"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1742-2094-6-42","article-title":"The chemokine CXCL13 is a key regulator of B cell recruitment to the cerebrospinal fluid in acute Lyme neuroborreliosis","volume":"6","author":"Rupprecht","year":"2009","journal-title":"J. Neuroloinflamm."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.cmi.2018.04.007","article-title":"Diagnostic value of cerebrospinal fluid CXCL13 for acute Lyme neuroborreliosis. A systematic review and meta-analysis","volume":"24","author":"Rupprecht","year":"2018","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2124390","DOI":"10.1155\/2018\/2124390","article-title":"Plasma Chemokine CCL2 and Its Receptor CCR2 Concentrations as Diagnostic Biomarkers for Breast Cancer Patients","volume":"2018","author":"Lubowicka","year":"2018","journal-title":"Biomed. Res. Int."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1016\/j.bbamcr.2014.05.014","article-title":"Cytokines and chemokines, at the crossroads of cell signalling and inflammatory disease","volume":"1843","author":"Turner","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1177\/10454411950060020101","article-title":"Chemokines, a family of chemotactic cytokines","volume":"6","author":"Graves","year":"1995","journal-title":"Crit. Rev. Oral Biol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1111\/febs.14466","article-title":"A guide to chemokines and their receptors","volume":"285","author":"Hughes","year":"2018","journal-title":"FEBS J."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1089\/wound.2012.0380","article-title":"Chemokines and Their Receptors Are Key Players in the Orchestra That Regulates Wound Healing","volume":"2","author":"Petreaca","year":"2013","journal-title":"Adv. Wound Care"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"15502","DOI":"10.1073\/pnas.1410700111","article-title":"Central domain of IL-33 is cleaved by mast cell proteases for potent activation of group-2 innate lymphoid cells","volume":"111","author":"Duval","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1084\/jem.187.4.655","article-title":"B cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1\/CXCR5","volume":"187","author":"Legler","year":"1998","journal-title":"J. Exp. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3389\/fendo.2019.00471","article-title":"CXCL13 and Its Receptor CXCR5 in Cancer, Inflammation, Immune Response, and Beyond","volume":"10","author":"Kazanietz","year":"2019","journal-title":"Front. Endocrinol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.2353\/ajpath.2010.090723","article-title":"Dendritic cells produce CXCL13 and participate in the development of murine small intestine lymphoid tissues","volume":"176","author":"McDonald","year":"2010","journal-title":"Am. J. Pathol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1182\/blood-2004-02-0701","article-title":"Monocyte-like and mature macrophages produce CXCL13 (B cell-attracting chemokine 1) in inflammatory lesions with lymphoid neogenesis","volume":"104","author":"Carlsen","year":"2004","journal-title":"Blood"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/35018581","article-title":"A chemokine-driven positive feedback loop organizes lymphoid follicles","volume":"406","author":"Ansel","year":"2000","journal-title":"Nature"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/imr.12752","article-title":"Concepts of GPCR-controlled navigation in the immune system","volume":"289","year":"2019","journal-title":"Immun. Rev."},{"key":"ref_26","first-page":"460","article-title":"Regulated Production of CXCL13 within the Central Nervous System","volume":"7","author":"Irani","year":"2016","journal-title":"J. Clin. Cell Immun."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jns.2014.09.027","article-title":"Laboratory diagnosis of Lyme neuroborreliosis is influenced by the test used, comparison of two ELISAs, immunoblot and CXCL13 testing","volume":"347","author":"Wutte","year":"2014","journal-title":"J. Neurol. Sci."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ttbdis.2017.12.008","article-title":"Neuroborreliosis and acute encephalopathy, The use of CXCL13 as a biomarker in CNS manifestations of Lyme borreliosis","volume":"9","author":"Karrasch","year":"2018","journal-title":"Ticks Tick Borne Dis."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s10096-013-2014-6","article-title":"Laboratory diagnosis of Lyme neuroborreliosis, a comparison of three CSF anti-Borrelia antibody assays","volume":"33","author":"Henningsson","year":"2014","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s00415-017-8669-7","article-title":"CXCL13 as a diagnostic marker of neuroborreliosis and other neuroinflammatory disorders in an unselected group of patients","volume":"265","author":"Wagner","year":"2018","journal-title":"J. Neurol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/1742-2094-9-93","article-title":"CXCL13 is the major determinant for B cell recruitment to the CSF during neuroinflammation","volume":"9","author":"Kowarik","year":"2012","journal-title":"J. Neuroloinflamm."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1186\/s12974-016-0745-x","article-title":"Cerebrospinal fluid cytokines in Lyme neuroborreliosis","volume":"13","author":"Maksimow","year":"2016","journal-title":"J. Neuroloinflamm."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/1742-2094-11-103","article-title":"CXCL13 and neopterin concentrations in cerebrospinal fluid of patients with Lyme neuroborreliosis and other diseases that cause neuroinflammation","volume":"11","author":"Kortela","year":"2014","journal-title":"J. Neuroloinflamm."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jns.2016.05.059","article-title":"Prospective study on the chemokine CXCL13 in neuroborreliosis and other aseptic neuroinfections","volume":"368","year":"2016","journal-title":"J. Neurol. Sci."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.diagmicrobio.2018.02.013","article-title":"Point-of-care testing for CXCL13 in Lyme neuroborreliosis","volume":"91","author":"Oksi","year":"2018","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Bremell, D., Mattsson, N., Edsbagge, M., Blennow, K., Andreasson, U., Wikkelso, C., Zetterberg, H., and Hagberg, L. (2013). Cerebrospinal fluid CXCL13 in Lyme neuroborreliosis and asymptomatic HIV infection. BMC Neurol., 13.","DOI":"10.1186\/1471-2377-13-2"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1128\/CVI.00353-13","article-title":"Diagnostic value of cytokines and chemokines in lyme neuroborreliosis","volume":"20","author":"Cerar","year":"2013","journal-title":"Clin. Vaccine Immun."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12974-017-0789-6","article-title":"Intrathecal Th17- and B cell-associated cytokine and chemokine responses in relation to clinical outcome in Lyme neuroborreliosis, a large retrospective study","volume":"14","author":"Gyllemark","year":"2017","journal-title":"J. Neuroloinflamm."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1212\/WNL.0b013e318211c3ed","article-title":"Are high CSF levels of CXCL13 helpful for diagnosis of Lyme neuroborreliosis?","volume":"76","author":"Tumani","year":"2011","journal-title":"Neurolology"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/apm.12596","article-title":"Evaluation of two assays for CXCL13 analysis in cerebrospinal fluid for laboratory diagnosis of Lyme neuroborreliosis","volume":"124","author":"Henningsson","year":"2016","journal-title":"APMIS"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/cid\/ciy019","article-title":"Neuroimmunomodulators in Neuroborreliosis and Lyme Encephalopathy","volume":"67","author":"Eckman","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1136\/jnnp.2009.195438","article-title":"The chemokine CXCL13 in acute neuroborreliosis","volume":"81","author":"Senel","year":"2010","journal-title":"J. Neurol. Neurolosurg. Psychiatry"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.imlet.2013.11.002","article-title":"Evaluation of CXCL8, CXCL10, CXCL11, CXCL12 and CXCL13 in serum and cerebrospinal fluid of patients with neuroborreliosis","volume":"157","author":"Moniuszko","year":"2014","journal-title":"Immun. Lett."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1007\/s10096-017-3049-x","article-title":"The recomBead Borrelia antibody index, CXCL13 and total IgM index for laboratory diagnosis of Lyme neuroborreliosis in children","volume":"36","author":"Skogman","year":"2017","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s10072-017-3227-8","article-title":"Chemokines CXCL10, CXCL11, and CXCL13 in acute disseminated encephalomyelitis, non-polio enterovirus aseptic meningitis, and neuroborreliosis, CXCL10 as initial discriminator in diagnostic algorithm?","volume":"39","author":"Maric","year":"2018","journal-title":"Neurol. Sci."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jinf.2010.11.005","article-title":"Diagnostic performance of cerebrospinal fluid chemokine CXCL13 and antibodies to the C6-peptide in Lyme neuroborreliosis","volume":"62","author":"Tjernberg","year":"2011","journal-title":"J. Infect."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s12974-017-0948-9","article-title":"Cerebrospinal fluid CXCL13 as a diagnostic marker of neuroborreliosis in children, a retrospective case-control study","volume":"14","author":"Remy","year":"2017","journal-title":"J. Neuroloinflamm."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1600-0404.2010.01477.x","article-title":"CXCL13 chemokine in pediatric and adult neuroborreliosis","volume":"124","author":"Wutte","year":"2011","journal-title":"Acta Neurol. Scand."},{"key":"ref_49","first-page":"2426313","article-title":"Clinical and Laboratory Characteristics of Symptomatic and Asymptomatic Neurosyphilis in HIV-Negative Patients, A Retrospective Study of 264 Cases","volume":"2019","author":"Li","year":"2019","journal-title":"Biomed. Res. Int."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"526","DOI":"10.3109\/00365548.2013.776700","article-title":"Cerebrospinal fluid chemokine CXCL13 in the diagnosis of neuroborreliosis in children","volume":"45","author":"Skogman","year":"2013","journal-title":"Scand. J. Infect. Dis."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1093\/infdis\/jix233","article-title":"Aberrant Humoral Immune Responses in Neurosyphilis, CXCL13\/CXCR5 Play a Pivotal Role for B-Cell Recruitment to the Cerebrospinal Fluid","volume":"216","author":"Yu","year":"2017","journal-title":"J. Infect. Dis."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1128\/JCM.02917-14","article-title":"Has CXCL13 an added value in diagnosis of neurosyphilis?","volume":"53","author":"Mothapo","year":"2015","journal-title":"J. Clin. Microbiol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/OLQ.0b013e3181d877a1","article-title":"CXCL13 as a cerebrospinal fluid marker for neurosyphilis in HIV-infected patients with syphilis","volume":"37","author":"Marra","year":"2010","journal-title":"Sex. Transm. Dis."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1177\/0956462415577229","article-title":"Value of CXCL13 in diagnosing asymptomatic neurosyphilis in HIV-infected patients","volume":"27","author":"Hu","year":"2016","journal-title":"Int. J. STD AIDS"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"33569","DOI":"10.1038\/srep33569","article-title":"CXCL13, CXCL10 and CXCL8 as Potential Biomarkers for the Diagnosis of Neurosyphilis Patients","volume":"6","author":"Wang","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"e8850","DOI":"10.1097\/MD.0000000000008850","article-title":"CXCL13 and TH1\/Th2 cytokines in the serum and cerebrospinal fluid of neurosyphilis patients","volume":"96","author":"Yan","year":"2017","journal-title":"Medicine"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"629","DOI":"10.12740\/PP\/97336","article-title":"Psychosis in Borrelia burgdorferi sensu lato infection\u2014Part I, epidemiology, pathogenesis, diagnosis and treatment of neuroborreliosis","volume":"53","author":"Nasierowski","year":"2019","journal-title":"Psychiatr. Pol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.3389\/fneur.2018.01048","article-title":"The Emerging Role of Microbial Biofilm in Lyme Neuroborreliosis","volume":"9","author":"Cavallo","year":"2018","journal-title":"Front. Neurol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"978","DOI":"10.5114\/aoms.2012.30948","article-title":"Lyme disease, review","volume":"8","author":"Biesiada","year":"2012","journal-title":"Arch. Med. Sci."},{"key":"ref_60","first-page":"930","article-title":"Neurological symptoms in infectious diseases","volume":"9","author":"Poleszak","year":"2019","journal-title":"J. Educ. Health Sport"},{"key":"ref_61","first-page":"34","article-title":"Differential diagnosis of late-stage neuroborreliosis with affection of the central nervous system","volume":"112","author":"Spirin","year":"2012","journal-title":"Zhurnal Nevrol. i Psikhiatrii Im. SS Korsakova"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Schwenkenbecher, P., Pul, R., Wurster, U., Conzen, J., Pars, K., Hartmann, H., S\u00fchs, K.W., Sedlacek, L., Stangel, M., and Trebst, C. (2017). Common and uncommon neurological manifestations of neuroborreliosis leading to hospitalization. BMC Infect. Dis., 17.","DOI":"10.1186\/s12879-016-2112-z"},{"key":"ref_63","first-page":"111","article-title":"Neuroborelioza","volume":"32","author":"Zajkowska","year":"1998","journal-title":"Neurol. Neurolochir. Pol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1468-1331.2009.02862.x","article-title":"European Federation of Neurological Societies. EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis","volume":"17","author":"Mygland","year":"2010","journal-title":"Eur. J. Neurol."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Reed, R.M., Bayly, W.M., and Sellon, D.C. (2018). Disorders of the Neurologic System. Equine Internal Medicine, Elsevier Inc.. [4th ed.].","DOI":"10.1016\/B978-0-323-44329-6.00016-4"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/s00508-018-1361-9","article-title":"Secondary dementia due to Lyme neuroborreliosis","volume":"130","author":"Kristoferitsch","year":"2018","journal-title":"Wien. Klin. Wochenschr."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000213070","article-title":"Clinical manifestations and diagnosis of lyme borreliosis","volume":"37","author":"Strle","year":"2009","journal-title":"Curr. Probl. Dermatol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1089\/jir.2016.0101","article-title":"Chemokine CXC Ligand 13 in Cerebrospinal Fluid Can Be Used as an Early Diagnostic Biomarker for Lyme Neuroborreliosis, A Meta-Analysis","volume":"37","author":"Yang","year":"2017","journal-title":"J. Interferon Cytokine Res."},{"key":"ref_69","unstructured":"World Health Organization (WHO) (2012, June 16). Prevalence and Incidence of Selected Sexually Transmitted Infections Chlamydia Trachomatis, Neisseria Gonorrhoeae, Syphilis and Trichomonas Vaginalis. Methods and Results Used by WHO to Generate 2005 Estimates. Available online: www.who.int\/reproductivehealth\/publications\/rtis\/9789241502450\/en\/."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"46","DOI":"10.5811\/cpcem.2019.9.43871","article-title":"Neurosyphilis, Old Disease, New Implications for Emergency Physicians","volume":"4","author":"Mercurio","year":"2019","journal-title":"Clin. Pract. Cases Emerg. Med."},{"key":"ref_71","first-page":"439","article-title":"Diagnostic tools for preventing and managing maternal and congenital syphilis, an overview","volume":"82","author":"Peeling","year":"2004","journal-title":"Bull. World Health Organ."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1155\/2005\/597580","article-title":"The laboratory diagnosis of syphilis","volume":"16","author":"Ratnam","year":"2005","journal-title":"Can. J. Infect. Dis. Med. Microbiol."},{"key":"ref_73","first-page":"48","article-title":"Association of CSF glucose concentration with neurosyphilis diagnosis","volume":"8","author":"Pastuszczak","year":"2013","journal-title":"Cent. Eur. J. Med."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions, explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/8\/2927\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T13:45:09Z","timestamp":1760363109000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/8\/2927"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,22]]},"references-count":74,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2020,4]]}},"alternative-id":["ijms21082927"],"URL":"https:\/\/doi.org\/10.3390\/ijms21082927","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,22]]}}}